LEAH Labs
PrivateLast Round
Grant
Oct 2, 2023
Est. Valuation
$2.14M
Total Funding Raised
$3.76M
Company Overview
LEAH Labs is a biotechnology company that develops curative CAR-T cell therapies for pets, with an initial focus on treating B cell lymphoma in dogs using its proprietary GeneWeld gene editing platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LEAH Labs Comparables
Compare LEAH Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CAVU Biotherapies | 86% | |
| Aurelius Biotherapeutics | 84% | |
| ELIAS Animal Health | 82% |
LEAH Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 2, 2023 | ||||
| Grant | Mar 1, 2022 | ||||
| Crowdfunding | Jul 1, 2021 | ||||
| Grant | Feb 22, 2021 | ||||
| Grant | May 11, 2020 | ||||
Angel | Mar 1, 2020 |
LEAH Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Ag Startup Engine | Seed |
| LaunchMN | Grant |
| NIH RADx | Grant |
| Regenerative Medicine Minnesota | Grant |
| Y Combinator | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 735% MoM, from 127 to 1.1K.
- Oct 2, 2023
Received $974K from the National Science Foundation.
LEAH Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LEAH Labs's valuation, stock price, and market status.
Is LEAH Labs a public or private company?
LEAH Labs is a private company.
What is the current stock price of LEAH Labs?
LEAH Labs is a private company, so its shares have no public market price. Caplight tracks LEAH Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LEAH Labs worth (valuation)?
LEAH Labs's valuation is estimated at $2.1M based on funding round data.
Can I buy LEAH Labs stock?
LEAH Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LEAH Labs's last funding round?
LEAH Labs's most recent funding round was Grant on October 2, 2023.
Who are the main investors in LEAH Labs?
Key investors in LEAH Labs include Ag Startup Engine, LaunchMN, NIH RADx, Y Combinator, National Science Foundation.
Will LEAH Labs IPO soon?
No public IPO plans have been announced for LEAH Labs.
How can I track LEAH Labs secondary market activity?
Caplight tracks bids, offers, and trades in LEAH Labs's shares on secondary markets.